Evidence map›Paper›PMID 26987985›Full record

ArticleBioscience reports2016

Acinar phenotype is preserved in human exocrine pancreas cells cultured at low temperature: implications for lineage-tracing of β-cell neogenesis.

Josué K Mfopou, Isabelle Houbracken, Elke Wauters, Iris Mathijs, Imane Song, Eddy Himpe, Jonathan Baldan, Harry Heimberg, Luc Bouwens

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Josué K MfopouCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Isabelle HoubrackenCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Elke WautersCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Iris MathijsCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Imane SongCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Eddy HimpeCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Jonathan BaldanCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Harry HeimbergBeta Cell Neogenesis, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium.
Luc BouwensCell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Brussels, BE 1090, Belgium lucbo@vub.ac.be.
Vrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regenerative medicine field is expanding with great successes in laboratory and preclinical settings. Pancreatic acinar cells in diabetic mice were recently converted into β-cells by treatment with ciliary neurotrophic factor (CNTF) and epidermal growth factor (EGF). This suggests that human acinar cells might become a cornerstone for diabetes cell therapy in the future, if they can also be converted into glucose-responsive insulin-producing cells. Presently, studying pancreatic acinar cell biology in vitro is limited by their high plasticity, as they rapidly lose their phenotype and spontaneously transdifferentiate to a duct-like phenotype in culture. We questioned whether human pancreatic acinar cell phenotype could be preserved in vitro by physico-chemical manipulations and whether this could be valuable in the study of β-cell neogenesis. We found that culture at low temperature (4°C) resulted in the maintenance of morphological and molecular acinar cell characteristics. Specifically, chilled acinar cells did not form the spherical clusters observed in controls (culture at 37°C), and they maintained high levels of acinar-specific transcripts and proteins. Five-day chilled acinar cells still transdifferentiated into duct-like cells upon transfer to 37°C. Moreover, adenoviral-mediated gene transfer evidenced an active Amylase promoter in the 7-day chilled acinar cells, and transduction performed in chilled conditions improved acinar cell labelling. Together, our findings indicate the maintenance of human pancreatic acinar cell phenotype at low temperature and the possibility to efficiently label acinar cells, which opens new perspectives for the study of human acinar-to-β-cell transdifferentiation.

Indexed as

Cell LineageAmylasesAnimalsCell Culture TechniquesCell DifferentiationCells, CulturedCell TransdifferentiationCold TemperatureHumansInsulin-Secreting CellsMicePancreas, ExocrinePhenotypePromoter Regions, GeneticTranscriptomeAmylasesacinar cellchilledhypothermiclineage tracingneogenesistransdifferentiationβ-cell

Identifiers

PMID26987985
PMCPMC4859086
OpenAlexW2311425550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.